Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Gérard M. London"'
Autor:
Davide Bolignano, Graziella D'Arrigo, Alberto Ortiz, Grégoire Wuerzner, Jean-Michel Halimi, Alexandre Persu, Liffert Vogt, Gérard M. London, Ioannis N Boletis, Michel Burnier, Francesca Mallamaci, Patrick Rossignol, Nada Kanaan, Pantelis Sarafidis, Charalampos Loutradis, Bénédicte Sautenet, Carmine Zoccali, Anna Pisano, Charles J. Ferro
Publikováno v:
Nephrology Dialysis Transplantation. 36:1326-1346
Background Few studies show that ambulatory blood pressure (BP) monitoring (ABPM) is superior to office BP (oBP) measurements to predict target organ damage and cardiovascular (CV) events in kidney transplant recipients (KTRs). We performed a systema
Autor:
Gérard M. London, Carmine Zoccali, Christodoulos Papadopoulos, Ioannis Tsouchnikas, Pantelis Sarafidis, Francesca Mallamaci, Maria Eleni Alexandrou, Robert Ekart, Vasileios Kamperidis, Charalampos Loutradis, Charles J. Ferro, Aikaterini Papagianni
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Hypertension is highly prevalent and independently associated with adverse outcomes in patients undergoing hemodialysis. The main mechanism leading to BP elevation in these individuals is their inability to maintain water homeosta
Autor:
Jürgen Floege, Enrique Rodríguez Rubio, Minerva Rodríguez García, Francesco Locatelli, José Luis Fernandez-Martin, Carmine Zoccali, Miguel Ángel Suárez Hevia, Martine Cohen-Solal, Jose Luis Gorriz Teruel, Carlos Gómez-Alonso, Gérard M. London, Jesús María Fernández Gómez, Jorge B. Cannata-Andía, Manuel Anibal A Ferreira, Pedro Barrera Baena, Beatriz Martín-Carro, Cristina Alonso-Montes, Markus Ketteler, Lucía González Llorente, Alberto Ortiz
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Bone fragility fractures (bone fractures) are extremely frequent in haemodialysis (HD) patients. Serum phosphate (P) has been suggested as a risk factor for bone fracture, nonetheless, evidence is poor. The aim of this study was t
Autor:
Jesús María Fernández Gómez, Cristina Alonso-Montes, Francesco Locatelli, J. Emilio Sánchez-Álvarez, Markus Ketteler, Miguel Ángel Suárez Hevia, Beatriz Martín-Carro, Gérard M. London, Jürgen Floege, Manuel Anibal A Ferreira, José Luis Fernandez-Martin, José Luis Górriz, Carmine Zoccali, Jorge B. Cannata-Andía
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Diabetes is the most common cause of chronic kidney disease (CKD) stage 5 and a relevant risk factor for mortality. The available CKD-MBD guidelines do not make differences between diabetics and non-diabetics regarding the optimal
Autor:
Panteleimon Sarafidis, Christodoulos Papadopoulos, Athanasios Bikos, Christoph Schmaderer, Gérard M. London, Aikaterini Papagianni, Efstathios D. Pagourelias, Vasileios Vassilikos, Christopher C. Mayer, Charalampos Loutradis, Siegfried Wassertheurer, Antonios Karpetas
Publikováno v:
European Heart Journal. 40
Introduction and purpose Hemodialysis patients have premature arterial stiffness, and the relationship between pulse wave velocity (PWV) and blood pressure (BP) may be different than in other hypertensives. Previous studies showed that when BP decrea
Autor:
B. Darne, Jean-Louis Bouchet, Eric Daugas, Guillaume Jean, Hubert Roth, Denis Fouque, Thierry Hannedouche, Gérard M. London, Tilman B. Drüeke
Publikováno v:
Clinical Kidney Journal
Background. The aim of the third French Phosphorus and Calcium Observatory (Photo-Graphe (R) 3) was to assess the achievement of international Kidney Disease: Improving Global Outcomes (KDIGO) recommendations on optimal serum phosphate, calcium and p
Autor:
Gunnar H. Heine, Danilo Fliser, Francesca Mallamaci, Sarah Seiler-Mußler, Kathrin Untersteller, Carmine Zoccali, Gérard M. London
Publikováno v:
Nephrology Dialysis Transplantation. 33:653-660
Background The Acute Dialysis Quality Initiative (ADQI) XI Workgroup has suggested defining heart failure (HF) in patients with end-stage renal disease by the presence of at least one out of eight predefined echocardiographic criteria. Given the high
Autor:
Alan Charney, Rajiv Agarwal, Bhupinder Singh, Dahlia Garza, David G. Warnock, Jonathan H. Seltzer, William C. Cushman, Salim Shah, Michael Walsh, Bengt Fellström, Peter G. M. Mol, Bernard Canaud, Nicolas Guzman, Janet Wittes, Faiez Zannad, Christopher S. Wilcox, Jonathan C. Craig, Bergur V. Stefánsson, Frank A. Holtkamp, Amil M. Shah, Gérard M. London, Luis M. Ruilope, Yves Rosenberg, Ron T. Gansevoort, Christoph Wanner, Ziad A. Massy, Gilles Chatellier, Aliza Thompson, Alexandre Mebazaa, Wendy Gattis Stough, Bertram Pitt, Kristian Thygesen, Marc A. Pfeffer, Norman Stockbridge, Patrick Rossignol
Publikováno v:
European Heart Journal, 40(11), 880-887. Oxford University Press
Rossignol, P, Agarwal, R, Canaud, B, Charney, A, Chatellier, G, Craig, J C, Cushman, W C, Gansevoort, R T, Fellström, B, Garza, D, Guzman, N, Holtkamp, F A, London, G M, Massy, Z A, Mebazaa, A, Mol, P G M, Pfeffer, M A, Rosenberg, Y, Ruilope, L M, Seltzer, J, Shah, A M, Shah, S, Singh, B, Stefánsson, B V, Stockbridge, N, Stough, W G, Thygesen, K, Walsh, M, Wanner, C, Warnock, D G, Wilcox, C S, Wittes, J, Pitt, B, Thompson, A & Zannad, F 2019, ' Cardiovascular outcome trials in patients with chronic kidney disease : Challenges associated with selection of patients and endpoints ', European Heart Journal, vol. 40, no. 11, pp. 880-886 . https://doi.org/10.1093/eurheartj/ehx209
Rossignol, P, Agarwal, R, Canaud, B, Charney, A, Chatellier, G, Craig, J C, Cushman, W C, Gansevoort, R T, Fellström, B, Garza, D, Guzman, N, Holtkamp, F A, London, G M, Massy, Z A, Mebazaa, A, Mol, P G M, Pfeffer, M A, Rosenberg, Y, Ruilope, L M, Seltzer, J, Shah, A M, Shah, S, Singh, B, Stefánsson, B V, Stockbridge, N, Stough, W G, Thygesen, K, Walsh, M, Wanner, C, Warnock, D G, Wilcox, C S, Wittes, J, Pitt, B, Thompson, A & Zannad, F 2019, ' Cardiovascular outcome trials in patients with chronic kidney disease : Challenges associated with selection of patients and endpoints ', European Heart Journal, vol. 40, no. 11, pp. 880-886 . https://doi.org/10.1093/eurheartj/ehx209
Although cardiovascular disease is a major health burden for patients with chronic kidney disease, most cardiovascular outcome trials have excluded patients with advanced chronic kidney disease. Moreover, the major cardiovascular outcome trials that
Autor:
Danilo Fliser, Fabio Lizzi, Giuseppe Pontoriero, Mauro Raciti, Pantelis Sarafidis, Mirko Passera, Luca Serasini, Thomas Bachelet, Itzchak Slotki, Krzysztof Letachowicz, Francesca Mallamaci, Marie-Jeanne Coudert-Krier, Vincenzo Panichi, Luna Gargani, Fotis Zarzoulas, Gérard M. London, Andrzej Wiecek, Aristeidis Stavroulopoulos, Alberto Caiazza, Olga Balafa, Carmine Zoccali, Thomas Kraemer, Giovanni Tripepi, Patrick Rossignol, Adrian Covic, Robert Ekart, Sarah Seiler-Mußler, Thierry Hannedouche, Mihai Onofriescu, Ziad A. Massy, Rocco Tripepi, Radovan Hojs, Claudia Torino, Eugenio Picano, Rosa Sicari, Alberto Martínez-Castelao, Marian Klinger, Enrico Fiaccadori, Linda Shavit
Publikováno v:
Scopus-Elsevier
Within the framework of the LUST trial (LUng water by Ultra-Sound guided Treatment to prevent death and cardiovascular events in high-risk end-stage renal disease patients), the European Renal and Cardiovascular Medicine (EURECA-m) working group of t
Autor:
Aikaterini Papagianni, Robert Ekart, Carmine Zoccali, Christodoulos Papadopoulos, Vasileios Sachpekidis, Nikolaos Pyrgidis, Charalampos Loutradis, Ioanna Minopoulou, Maria Eleni Alexandrou, Dorothea Papadopoulou, Pantelis Sarafidis, Gérard M. London
Publikováno v:
Nephrology Dialysis Transplantation. 34